Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
105,841,018
-
Total 13F shares
-
1,656,864
-
Share change
-
-46,753
-
Total reported value
-
$11,065,000
-
Put/Call ratio
-
70%
-
Price per share
-
$6.68
-
Number of holders
-
21
-
Value change
-
-$276,577
-
Number of buys
-
9
-
Number of sells
-
11
Institutional Holders of SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) as of Q1 2022
As of 31 Mar 2022,
SELLAS Life Sciences Group, Inc. - Common Stock, par value $0.0001 per share (SLS) was held by
21 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,656,864 shares.
The largest 10 holders included
VANGUARD GROUP INC, BlackRock Inc., GEODE CAPITAL MANAGEMENT, LLC, Equitable Holdings, Inc., SUSQUEHANNA INTERNATIONAL GROUP, LLP, AMERIPRISE FINANCIAL INC, MORGAN STANLEY, STATE STREET CORP, PRELUDE CAPITAL MANAGEMENT, LLC, and D. E. Shaw & Co., Inc..
This page lists
21
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.